Processa Pharmaceuticals Inc PCSA Balance Sheet

Income Statement

Quarter End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	21.66M	18.6M	8.62M	12.43M	10.09M	8.08M	5.79M	9.95M
Total Current Assets	13.96M	10.89M	8.39M	12.22M	9.9M	7.91M	5.63M	9.8M
Cash and Equivalents	12.06M	9.06M	6.5M	10.74M	8.68M	6.86M	4.71M	8.92M
Total Non-Current Assets	7.7M	7.72M	233k	213k	193k	176k	155k	145k
Total Liabilities	1.58M	1.36M	1.15M	2.29M	930k	915k	798k	1.06M
Total Current Liabilities	1.57M	1.19M	999k	2.16M	821k	826k	731k	1.01M
Total Non-Current Liabilities	5k	172k	150k	129k	109k	89k	67k	57k
Common Equity	2k	2k	2k	2k	2k	2k	0	0
Retained Earnings	-45.22M	-51.24M	-64.25M	-68.27M	-70.88M	-72.96M	-75.37M	-78.1M

Year End December 30 2023	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	13.22M	10.88M	25.21M	26.46M	8.62M	5.79M
Total Current Assets	2.02M	1.01M	16.2M	18.33M	8.39M	5.63M
Cash and Equivalents	1.74M	692k	15.42M	16.5M	6.5M	4.71M
Total Non-Current Assets	9.7M	8.01M	22.94M	25.49M	7.47M	4.99M
Total Liabilities	2.78M	2.87M	2.28M	979k	1.15M	798k
Total Current Liabilities	646k	1.19M	1.22M	971k	999k	731k
Total Non-Current Liabilities	2.13M	1.68M	1.1M	8k	150k	67k
Total Equity	9.7M	8.01M	22.94M	25.49M	7.47M	4.99M
Common Equity	4k	1,000	1,000	2k	2k	0
Retained Earnings	-7.62M	-10.98M	-25.4M	-36.82M	-64.25M	-75.37M